<- Go home

Added to YB: 2026-02-13

Pitch date: 2026-02-08

SRT.DE [neutral]

Sartorius Aktiengesellschaft

+3.44%

current return

Author Info

No bio for this author

Company Info

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management products; buffers; reagents; plasmids; cellcelector flexs, incubator flowboxes, nanowell arrays, and capillaries and tips; high-throughput screening by cytometry; ultrafiltration solutions; syringe, membrane, glass and quartz microfiber, clarification, syringeless, and in-line filters; and lab chromatography, and filters and blotting papers.

Market Cap

EUR 14.6B

Pitch Price

EUR 186.00

Price Target

N/A

Dividend

0.32%

EV/EBITDA

22.35

P/E

N/A

EV/Sales

5.56

Sector

Life Sciences Tools and Services

Category

growth

Show full summary:
SGA International Growth Portfolio Holding: Sartorius Aktiengesellschaft

SRT.DE (holding update): Q3 sales +10% CC, EPS +27% on bioprocessing recovery (80% sales, +11% CC growth) as consumables rebound from post-pandemic destocking & equipment stabilizes. Lab products (R&D) weak. Mgmt raised FY guidance on improving biopharma outlook. High recurring revenue, strong position, innovation support high-teens EPS growth est. over 3yrs.

Read full article (1 min)